Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L McAfee

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Obstetrics & Gynecology|February 27, 1999
High dose chemotherapeutic strategies in the treatment of epithelial ovarian carcinomaS L McAfee, M V Seiden
The Journal of Infusional Chemotherapy|January 1, 1996
Methods of stem cell mobilizationA Dasgupta, D M Willerford, S L McAfee
Bone Marrow Transplantation|June 19, 1998
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantationC Colby, S L McAfee, D M Finkelstein, et al.
Bone Marrow Transplantation|April 18, 2002
High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplantC Colby, S Koziol, S L McAfee, et al.
Bone Marrow Transplantation|October 12, 1999
Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantationH C Toh, S L McAfee, R Sackstein, et al.
Psychosomatic Medicine|April 30, 1998
A comparison of related and unrelated marrow donorsG Chang, C McGarigle, T R Spitzer, et al.
Bone Marrow Transplantation|February 2, 2000
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II studyH C Toh, S L McAfee, R Sackstein, et al.
Bone Marrow Transplantation|November 14, 2017
Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impactM R Dowling, S Li, B R Dey, et al.
Bone Marrow Transplantation|October 9, 2012
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHDY-B Chen, S McDonough, H Chen, et al.
Bone Marrow Transplantation|November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantationR L Haspel, G Kao, B Y Yeap, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Obstetrics & Gynecology|February 27, 1999
High dose chemotherapeutic strategies in the treatment of epithelial ovarian carcinomaS L McAfee, M V Seiden
The Journal of Infusional Chemotherapy|January 1, 1996
Methods of stem cell mobilizationA Dasgupta, D M Willerford, S L McAfee
Bone Marrow Transplantation|June 19, 1998
Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantationC Colby, S L McAfee, D M Finkelstein, et al.
Bone Marrow Transplantation|April 18, 2002
High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplantC Colby, S Koziol, S L McAfee, et al.
Bone Marrow Transplantation|October 12, 1999
Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantationH C Toh, S L McAfee, R Sackstein, et al.
Psychosomatic Medicine|April 30, 1998
A comparison of related and unrelated marrow donorsG Chang, C McGarigle, T R Spitzer, et al.
Bone Marrow Transplantation|February 2, 2000
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II studyH C Toh, S L McAfee, R Sackstein, et al.
Bone Marrow Transplantation|November 14, 2017
Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impactM R Dowling, S Li, B R Dey, et al.
Bone Marrow Transplantation|October 9, 2012
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHDY-B Chen, S McDonough, H Chen, et al.
Bone Marrow Transplantation|November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantationR L Haspel, G Kao, B Y Yeap, et al.
Pageof 1